Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_4
2
25%
Ph phase_3
5
63%

Phase Distribution

0

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
5(71.4%)
Phase 4Post-market surveillance
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Other(1)

Detailed Status

Completed7
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 35 (71.4%)
Phase 42 (28.6%)

Trials by Status

unknown113%
completed788%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_3

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

NCT00171002
completedphase_3

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

NCT00170963
completedphase_4

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

NCT01241487
unknown

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

NCT02415192
completedphase_4

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

NCT01167153
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00171002Phase 3

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

Completed
NCT00170963Phase 3

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Completed
NCT01241487Phase 4

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

Completed
NCT02415192

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

Unknown
NCT01167153Phase 4

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

Completed
NCT00171535Phase 3

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

Completed
NCT00409851Phase 3

One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension

Completed
NCT00548067Phase 3

Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8